Ed Casabar
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 4
-
- Antibiotic Use and Resistance 8
- Co-authors
- David J. Ritchie (9 shared papers)Peggy S. McKinnon (4 shared papers)Richard M. Reichley (4 shared papers)Marc D. Smith (3 shared papers)Gerald Medoff (3 shared papers)James L. Gray (3 shared papers)W. Claiborne Dunagan (3 shared papers)Robert S. Woodward (3 shared papers)
- Journals
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)Clinical Infectious Diseases (2 papers)Infection Control and Hospital Epidemiology (2 papers)The American Journal of Medicine (2 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Ed Casabar
20 papers receiving 560 citations
Peers
Comparison fields: 5 of 69
- Applied Microbiology and Biotechnology 187
- Clinical Biochemistry 135
- Geriatrics and Gerontology 59
- Critical Care and Intensive Care Medicine 74
- Pharmacology 150
Countries citing papers authored by Ed Casabar
This map shows the geographic impact of Ed Casabar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Casabar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Casabar more than expected).
Fields of papers citing papers by Ed Casabar
This network shows the impact of papers produced by Ed Casabar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Casabar. The network helps show where Ed Casabar may publish in the future.
Co-authors
The 25 scholars most cited alongside Ed Casabar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 113 | |
| 2 | A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions. | 1997 | 58 |
| 3 | 2010 | 56 | |
| 4 | 1991 | 52 | |
| 5 | 1997 | 50 | |
| 6 | 2010 | 45 | |
| 7 | 2010 | 44 | |
| 8 | 2007 | 38 | |
| 9 | 1989 | 23 | |
| 10 | 2011 | 22 | |
| 11 | 2011 | 18 | |
| 12 | 2001 | 16 | |
| 13 | 2016 | 12 | |
| 14 | 2009 | 9 | |
| 15 | 2017 | 9 | |
| 16 | 2018 | 8 | |
| 17 | 1989 | 5 | |
| 18 | 2021 | 4 | |
| 19 | 2019 | 1 | |
| 20 | 2012 | 1 |
About Ed Casabar
Ed Casabar is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Pharmacology, Clinical Biochemistry and Epidemiology, having authored 20 papers that have together received 584 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (8 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Innovations in Medical Education (2 papers), Cytomegalovirus and herpesvirus research (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (187 citations), Clinical Biochemistry (135 citations), Geriatrics and Gerontology (59 citations), Critical Care and Intensive Care Medicine (74 citations) and Pharmacology (150 citations). Ed Casabar has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include David J. Ritchie, Peggy S. McKinnon, Richard M. Reichley, Marc D. Smith, Gerald Medoff, James L. Gray, W. Claiborne Dunagan, Robert S. Woodward, Thomas C. Bailey and Edward Spitznagel. Their work appears in journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, Infection Control and Hospital Epidemiology and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.